New research shows a single psilocybin session with therapy can reduce depression in cancer patients for up to two years.

A first-of-its-kind clinical trial shows that ketamine treatment for severe, treatment-resistant depression is significantly more effective when paired with psychotherapy and supportive environments.

About half of patients had sustained reduction in depression and anxiety up to two years after psilocybin and psychotherapy.

Colorado policymakers, including Gov. Jared Polis and Attorney General Phil Weiser, expressed enthusiasm about the potential ...

The Federal Court of Appeal is ordering Canada's Health Minister to rethink a 2022 refusal to grant exemptions to 96 ...

SANTA FE — New Mexico this week becomes the third state to launch a state-run medical psilocybin program, but don't expect magic mushrooms to be widely offered any time soon. State officials have ...

Ketamine leads to increased communication between areas of the brain that don't typically engage with each other, new ...

A groundbreaking study reveals that a single dose of psilocybin, the active compound in magic mushrooms, can provide ...